Skip to main content
SpringerLink
Log in

The neurological mutant quaking viable is Parkin deficient

  • Original Contribution
  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

The mouse mutant quaking viable (qk v) has been studied for almost four decades as a model for dysmyelination of the central nervous system (CNS). The genetic lesion associated with the qk v phenotype is a large deletion of approximately 1 Megabase on mouse Chromosome (Chr) 17. This deficiency alters the expression of transcripts from the qkI locus in oligodendrocytes, resulting in improper myelination of the CNS in animals homozygous for the deletion. To determine whether other genes within the deletion contribute to the quaking viable phenotype, we physically mapped and sequenced the deleted interval. We determined that the mouse Parkin gene, as well as the Parkin co-regulated gene (Pacrg), lies within the qk v deletion. We determined that qk v mutants completely lack the expression of the Parkin gene product. Loss-of-function mutations in the human PARKIN gene cause autosomal juvenile Parkinson’s disease (AR-JP). Our studies show that the deletion of Parkin in qk v brains does not result in the loss of dopaminergic neurons typical of AR-JP patients. Also, α-synuclein, a target of Parkin-dependent ubiquitination, does not accumulate in qk v mutant brains. Despite the lack of AR-JP-like neuropathology in qk v mice, this mutant may constitute a readily available model for the study of the cellular function of Parkin. This is the first report of a gene distinct from qkI affected by the qk v deletion. The discovery of the multigenic nature of this classical mouse mutation calls for the re-evaluation of its phenotypic characterization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. WW Cai J Reneker CW Chow M Vaishnav A Bradley (1998) ArticleTitleAn anchored framework BAC map of mouse chromosome 11 assembled using multiplex oligonucleotide hybridization. Genomics 54 387–397

    Google Scholar 

  2. KK Chung Y Zhang KL Lim Y Tanaka H Huang et al. (2001) ArticleTitleParkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7 1144–1150 Occurrence Handle1:CAS:528:DC%2BD3MXns12kurg%3D Occurrence Handle11590439

    CAS  PubMed  Google Scholar 

  3. O Corti C Hampe H Koutnikova F Darios S Jacquier et al. (2003) ArticleTitleThe p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12 1427–1437 Occurrence Handle10.1093/hmg/ddg159 Occurrence Handle1:CAS:528:DC%2BD3sXksVWqsbY%3D Occurrence Handle12783850

    Article  CAS  PubMed  Google Scholar 

  4. RD Cox A Shedlovsky R Hamvas M Goldsworthy J Whittington et al. (1994) ArticleTitleA 1.2-Mb YAC contig spans the quaking region. Genomics 21 77–84 Occurrence Handle10.1006/geno.1994.1227 Occurrence Handle1:CAS:528:DyaK2MXhsVemtg%3D%3D Occurrence Handle8088820

    Article  CAS  PubMed  Google Scholar 

  5. RD Cox A Hugill A Shedlovsky JK Noveroske S Best et al. (1999) ArticleTitleContrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics 57 333–341 Occurrence Handle10.1006/geno.1999.5804 Occurrence Handle1:CAS:528:DyaK1MXivFOrtr8%3D Occurrence Handle10328999

    Article  CAS  PubMed  Google Scholar 

  6. F Darios O Corti CB Lucking C Hampe MP Muriel et al. (2003) ArticleTitleParkin prevents mitochondrial swelling and cytochrome C release in mitochondria-dependent cell death. Hum Mol Genet 12 517–526 Occurrence Handle10.1093/hmg/ddg044 Occurrence Handle1:CAS:528:DC%2BD3sXisFSlu7c%3D Occurrence Handle12588799

    Article  CAS  PubMed  Google Scholar 

  7. T Ebersole O Rho K Artzt (1992) ArticleTitleThe proximal end of mouse chromosome 17: new molecular markers identify a deletion associated with quakingviable. Genetics 131 183–190 Occurrence Handle1:STN:280:By2B2srjtFM%3D Occurrence Handle1592235

    CAS  PubMed  Google Scholar 

  8. TA Ebersole Q Chen MJ Justice K Artzt (1996) ArticleTitleThe quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet 12 260–265 Occurrence Handle1:CAS:528:DyaK28XhvVSgtL0%3D Occurrence Handle8589716

    CAS  PubMed  Google Scholar 

  9. MS Goldberg SM Fleming JJ Palacino C Cepeda HA Lam et al. (2003) ArticleTitleParkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278 43628–43635 Occurrence Handle10.1074/jbc.M308947200 Occurrence Handle1:CAS:528:DC%2BD3sXosFSrsbk%3D Occurrence Handle12930822

    Article  CAS  PubMed  Google Scholar 

  10. RJ Hardy CL Loushin VL Jr Friedrich Q Chen TA Ebersole et al. (1996) ArticleTitleNeural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci 16 7941–7949 Occurrence Handle1:CAS:528:DyaK28XnsF2ktb0%3D Occurrence Handle8987822

    CAS  PubMed  Google Scholar 

  11. Y Imai M Soda H Inoue N Hattori Y Mizuno et al. (2001) ArticleTitleAn unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105 891–902 Occurrence Handle10.1016/S0092-8674(01)00407-X Occurrence Handle1:CAS:528:DC%2BD3MXltVeqtr0%3D Occurrence Handle11439185

    Article  CAS  PubMed  Google Scholar 

  12. JM Itier P Ibanez MA Mena N Abbas C Cohen-Salmon et al. (2003) ArticleTitleParkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12 2277–2291 Occurrence Handle10.1093/hmg/ddg239 Occurrence Handle1:CAS:528:DC%2BD3sXntVCru74%3D Occurrence Handle12915482

    Article  CAS  PubMed  Google Scholar 

  13. MJ Justice VC Bode (1988) ArticleTitleThree ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations. Genet Res 51 95–102 Occurrence Handle1:CAS:528:DyaL1cXlt1KntL0%3D Occurrence Handle3410318

    CAS  PubMed  Google Scholar 

  14. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura et al. (1998) ArticleTitleMutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 605–608 Occurrence Handle1:CAS:528:DyaK1cXis1Sqsrc%3D Occurrence Handle9560156

    CAS  PubMed  Google Scholar 

  15. MK Lee W Stirling Y Xu X Xu D Qui et al. (2002) ArticleTitleHuman alpha-synuclein-harboring familial Parkinson’s disease-linked Ala- 53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99 8968–8973 Occurrence Handle10.1073/pnas.132197599 Occurrence Handle1:CAS:528:DC%2BD38XltF2htbk%3D Occurrence Handle12084935

    Article  CAS  PubMed  Google Scholar 

  16. E Masliah E Rockenstein I Veinbergs M Mallory M Hashimoto et al. (2000) ArticleTitleDopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 1265–1269 Occurrence Handle10.1126/science.287.5456.1265 Occurrence Handle1:CAS:528:DC%2BD3cXhtlOqsL4%3D Occurrence Handle10678833

    Article  CAS  PubMed  Google Scholar 

  17. H Matsumine M Saito S Shimoda-Matsubayashi H Tanaka A Ishikawa et al. (1997) ArticleTitleLocalization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 60 588–596

    Google Scholar 

  18. Y Matsuoka M Vila S Lincoln A McCormack M Picciano et al. (2001) ArticleTitleLack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8 535–539 Occurrence Handle10.1006/nbdi.2001.0392 Occurrence Handle1:CAS:528:DC%2BD3MXkvFChu7s%3D Occurrence Handle11442360

    Article  CAS  PubMed  Google Scholar 

  19. EM Nikulina JA Skrinskaya DF Avgustinovich NK Popova (1995) ArticleTitleDopaminergic brain system in the quaking mutant mouse. Pharmacol Biochem Behav 50 333–337 Occurrence Handle10.1016/0091-3057(94)00267-M Occurrence Handle1:CAS:528:DyaK2MXjvFKrsbY%3D Occurrence Handle7617670

    Article  CAS  PubMed  Google Scholar 

  20. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia et al. (1997) ArticleTitleMutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276 2045–2047 Occurrence Handle1:CAS:528:DyaK2sXkt1altr4%3D Occurrence Handle9197268

    CAS  PubMed  Google Scholar 

  21. Y Ren J Zhao J Feng (2003) ArticleTitleParkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci 23 3316–3324 Occurrence Handle1:CAS:528:DC%2BD3sXjsFSktrg%3D Occurrence Handle12716939

    CAS  PubMed  Google Scholar 

  22. H Shimura N Hattori S Kubo Y Mizuno S Asakawa et al. (2000) ArticleTitleFamilial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25 302–305 Occurrence Handle1:STN:280:DC%2BD3czptF2nsw%3D%3D Occurrence Handle10888878

    CAS  PubMed  Google Scholar 

  23. H Shimura MG Schlossmacher N Hattori MP Frosch A Trockenbacher et al. (2001) ArticleTitleUbiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson’s disease. Science 293 263–269 Occurrence Handle1:CAS:528:DC%2BD3MXlt1yitL4%3D Occurrence Handle11431533

    CAS  PubMed  Google Scholar 

  24. RL, Dickie MM, Appel SH Sidman (1964) ArticleTitleMutant mice (Quaking and Jimpy) with deficient myelination in central nervous system. Science 144 309–311 Occurrence Handle1:STN:280:CCuC38jntVU%3D Occurrence Handle14169723

    CAS  PubMed  Google Scholar 

  25. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes et al. (1997) ArticleTitleAlpha-synuclein in Lewy bodies. Nature 388 839–840 Occurrence Handle1:CAS:528:DyaK2sXlslWru7o%3D Occurrence Handle9278044

    CAS  PubMed  Google Scholar 

  26. MG Spillantini RA Crowther R Jakes M Hasegawa M Goedert (1998) ArticleTitlealpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95 6469–6473 Occurrence Handle10.1073/pnas.95.11.6469 Occurrence Handle1:CAS:528:DyaK1cXjtlKgtLo%3D Occurrence Handle9600990

    Article  CAS  PubMed  Google Scholar 

  27. JF Staropoli C McDermott C Martinat B Schulman E Demireva et al. (2003) ArticleTitleParkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37 735–749 Occurrence Handle1:CAS:528:DC%2BD3sXitlSrsL8%3D Occurrence Handle12628165

    CAS  PubMed  Google Scholar 

  28. CC Stichel M Augustin K Kuhn XR Zhu P Engels et al. (2000) ArticleTitleParkin expression in the adult mouse brain. Eur J Neurosci 12 4181–4194 Occurrence Handle10.1046/j.1460-9568.2000.01314.x Occurrence Handle1:STN:280:DC%2BD3M7itVantA%3D%3D Occurrence Handle11122330

    Article  CAS  PubMed  Google Scholar 

  29. H Takahashi E Ohama S Suzuki Y Horikawa A Ishikawa et al. (1994) ArticleTitleFamilial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44 437–441 Occurrence Handle1:STN:280:ByuC1MrkvFE%3D Occurrence Handle8145912

    CAS  PubMed  Google Scholar 

  30. AB West PJ Lockhart C O’Farell MJ Farrer (2003) ArticleTitleIdentification of a novel gene linked to parkin via a bi-directional promoter. J Mol Biol 326 11–19 Occurrence Handle10.1016/S0022-2836(02)01376-1 Occurrence Handle1:CAS:528:DC%2BD3sXlt12hsw%3D%3D Occurrence Handle12547187

    Article  CAS  PubMed  Google Scholar 

  31. JT Winston C Chu JW Harper (1999) ArticleTitleCulprits in the degradation of cyclin E apprehended. Genes Dev 13 2751–2757 Occurrence Handle1:CAS:528:DyaK1MXnsVGgt7c%3D Occurrence Handle10557204

    CAS  PubMed  Google Scholar 

  32. Y Zhang J Gao KK Chung H Huang VL Dawson et al. (2000) ArticleTitleParkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97 13354–13359 Occurrence Handle1:CAS:528:DC%2BD3cXosVOjs7o%3D Occurrence Handle11078524

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Room S413, Houston, Texas 77030, USA

    Diego Lorenzetti & Monica Justice

  2. Department of Pathology, Baylor College of Medicine, Houston, Texas, USA

    Barbara Antalffy & Dawna Armstrong

  3. Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA

    Hannes Vogel

  4. The Jackson Laboratory, Bar Harbor, Maine, USA

    Janice Noveroske

Authors
  1. Diego Lorenzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Antalffy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hannes Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Janice Noveroske
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dawna Armstrong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monica Justice
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Justice.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorenzetti, D., Antalffy, B., Vogel, H. et al. The neurological mutant quaking viable is Parkin deficient . Mamm Genome 15, 210–217 (2004). https://doi.org/10.1007/s00335-003-2333-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-003-2333-5

Keywords

Search

Navigation